Radiation or observation after surgery for low-risk meningioma
This trial compares two approaches for people who have had surgery to remove a meningioma, a usually non-cancerous brain tumor. Depending on the tumor's risk level, participants either receive radiation therapy or are observed without additional treatment, to see which approach provides better control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had surgery to remove a meningioma within the last 6 months.
- The tumor was completely or partially removed, confirmed by an MRI after surgery.
- Your tumor is a type called WHO grade 1 or 2 meningioma.
- You have not had radiation therapy to the head in the last 10 years that would overlap with this treatment area.
- You are generally in good health, with no serious heart problems or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether people with a grade II meningioma that has been completely removed by surgery should be monitored only or treated with radiation. It may help reduce the risk of the tumor coming back while balancing radiation side effects.
This trial studies whether radiation given after complete surgery can reduce regrowth of atypical (grade II) meningioma in certain people. It is mainly for tumors that did not involve the brain’s venous sinus and for patients who can safely have follow-up brain MRI scans.
This study tests a type of focused radiation therapy (called stereotactic radiosurgery) given after surgery for certain meningiomas. The goal is to see if this treatment helps prevent the tumor from coming back, and to check its safety.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This trial studies how patients with grade 2 or 3 low-grade brain gliomas do after modern radiotherapy following surgery (or biopsy). It looks at both brain/memory functioning and cancer outcomes, especially for people at higher risk from their surgery or age.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
Hear when a new Grade 1 Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.